Bloomberg Business Week | Can You Trust Generics?
An FDA quality-control nightmare reveals how impurities end up in America’s blood pressure pills.
The September 2019 print issue of Bloomberg Business Week featured a cover story titled "Can You Trust Generics?" The 8-page spread delves into the fact that 90% of pharmaceuticals sold in the US are generics and highlights the recent discovery of the chemical N-Nitrosodimethylamine, or NDMA, in batches of commonly used generic drugs. The article raises a crucial question: "Valsartan is just the one we caught. Who knows how many more are out there?"
Furthermore, the article was adapted for online release on Bloomberg with the title "Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.."
